WOBURN, Mass.--(BUSINESS WIRE)--Sirtex Medical Limited (ASX: SRX) today announced that SIR-Spheres ® Y-90 resin microspheres has been included as a Category 2A recommended treatment in the latest ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile
Părere